Prof. Giuseppe Francesco Milone

Ha una esperienza di circa 30 anni nella diagnosi e trattamento delle malattie ematologiche.
Ha effettuato per primo in Sicilia il trapianto di midollo osseo nel 1987. Ha studiato la tecnica di trapianto di midollo negli Stati Uniti nel 1982 e quindi nel 1995.
Ha effettuato 1250 trapianti di midollo autologhi e allogenici.
Ha conseguito l'idoneità a professore ordinario di Ematologia.
E' socio della società americana di Ematologia e della società europea di per il trapianto di cellule staminali emopoietiche.
E' autore di 125 pubblicazioni in riviste internazionali.

• Universita degli studi di Catania
• Universita' di SEATTLE USA (fred Hutchinson Cancer Center)
• Universita' del TEXAS MD ANDERSON

• Inglese
• Italiano

• Membro del COMITATO REGIONALE TRAPIANTI
• Responsabile della commissione attività Formative della Società Scientifica Gruppo Italiano Trapianto di Midollo

• www.ematologo-milone.com
• immettere su google l'indirizzo seguente = sciprofiles.com/profile/1384199
• Revisore e moderatore a vari convegni e congressi nazionali in ambito ematologico
• infused suspension and patient age. Cytotherapy. 2007;9(4):348-55. doi:
• of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the
• Murgano P, Farsaci B, Privitera A, Giustolisi R. Adverse events after infusions
• 77: Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, Coppoletta S,
• patients. Leuk Lymphoma. 2007 Oct;48(10):1950-60. doi:
• cyclophosphamide 4 g/m(2) plus G-CSF 10 g/kg in PBSC mobilization of lymphoma
• Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than
• M, Coppoletta S, Mauro E, Avola G, Pinto V, Camuglia MG, Giustolisi R.
• 76: Milone G, Leotta S, Battiato K, Murgano P, Mercurio S, Strano A, Poidomani
• Transplant Research. Bone Marrow Transplant. 2008 Apr;41(7):635-42. doi:
• National Marrow Donor Program and Center for International Blood and Marrow
• unrelated donor bone marrow transplantation: a comparative analysis by the
• outcomes of adults with acute lymphoblastic leukemia after autologous or
• Keating A, Loberiza FR Jr, Giralt S, Horowitz MM, Weisdorf DJ. Long-term
• Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G,
• 75: Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR,
• burnout: an Italian survey. Br J Cancer. 2008 Mar 25;98(6):1046-52. doi:
• A, Corrao G, Lambertenghi-Deliliers G, Invernizzi G. Haemato-oncology and
• G, Milone G, Miccolis IR, Pavanetto M, Pescador L, Poddigue M, Scotti L, Zambon
• 74: Bressi C, Manenti S, Porcellana M, Cevales D, Farina L, Felicioni I, Meloni
• Italiano Trapianto di Midollo Osseo (GITMO). Blood. 2008 Aug 1;112(3):895-902.
• outcome in patients with myelodysplastic syndrome: a study from the Gruppo
• Midollo Osseo (GITMO). WHO classification and WPSS predict posttransplantation
• Malcovati L, Pascutto C, Oneto R, Fanin R, Bosi A; Gruppo Italiano Trapianto di
• F, Bernardi M, Iori AP, Rambaldi A, Cerretti R, Marenco P, Pioltelli P,
• 73: Alessandrino EP, Della Porta MG, Bacigalupo A, Van Lint MT, Falda M, Onida
• Jan;23(1):199-203. doi: 10.1038/leu.2008.170. Epub 2008 Jul 3. PMID: 18596743.
• mutated nucleophosmin (NPM1) in the same family. Leukemia. 2009
• Biondi A, Falini B. Simultaneous occurrence of acute myeloid leukaemia with
• Mirabile E, Costantino F, Martelli MP, Mastrodicasa E, Di Raimondo F, Aversa F,
• 72: Cazzaniga G, Lo Nigro L, Cifola I, Milone G, Schnittger S, Haferlach T,
• myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di
• R, Bosi A; GITMO. Allogeneic hematopoietic stem cell transplantation in
• MT, Iori AP, Santarone S, Porretto F, Pioltelli P, Visani G, Iacopino P, Fanin
• 71: Patriarca F, Bacigalupo A, Sperotto A, Isola M, Soldano F, Bruno B, van Lint
• Oct;14(10):1134-1140. doi: 10.1016/j.bbmt PMID: 18804043; PMCID:
• autologous stem cell transplantation. Biol Blood Marrow Transplant. 2008
• Hari P. Comparable outcomes in nonsecretory and secretory multiple myeloma after
• McCarthy PL, Milone GA, Moreb JS, Pavlovsky S, Reece DE, Vesole DH, Wiernik PH,
• MS, Elfenbein GJ, Freytes CO, Gale RP, Gibson J, Kyle RA, Lacy MQ, Lazarus HM,
• 70: Kumar S, Pérez WS, Zhang MJ, Ballen K, Bashey A, To LB, Bredeson CN, Cairo
• 10.1182/b111d . Epub 2009 Jun 10. PMID: 19515726.
• stem cell transplantation. Blood. 2009 Aug 13;114(7):1437-44. doi:
• significant independent risk factor for mortality after unrelated hematopoietic
• Italian Bone Marrow Donor Registry. Nonpermissive HLA-DPB1 disparity is a
• Midollo Osseo, Cellule Staminale Ematopoietiche (CSE) e Terapia Cellulare;
• Bosi A, Ciceri F, Bacigalupo A, Fleischhauer K; Gruppo Italiano Trapianto di
• Sormani MP, Marcon J, Lamparelli T, Fanin R, Garbarino L, Miotti V, Bandini G,
• 69: Crocchiolo R, Zino E, Vago L, Oneto R, Bruno B, Pollichieni S, Sacchi N,
• Jul 6. PMID: 19584823.
• Marrow Transplant. 2010 Feb;45(2):385-91. doi: 10.1038/bmt.2009.151. Epub 2009
• thymocyte globulin, given on day+7 after alternative donor transplants. Bone
• emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-
• Pinto V, Van Lint MT; Gruppo Italiano Trapianto Midollo Osseo (GITMO). Pre-
• Locasciulli A, Majolino I, Di Bartolomeo P, Mazza F, Sacchi N, Pollicheni S,
• 68: Bacigalupo A, Lamparelli T, Milone G, Sormani MP, Ciceri F, Peccatori J,
• 10.1182/b111d . Epub 2010 Mar 10. PMID: 20220116.
• typing and donor availability. Blood. 2010 May 6;115(18):3671-7. doi:
• after autologous transplantation: a retrospective study based on the time of HLA
• the overall and progression-free survival of Hodgkin lymphoma patients relapsing
• Gruppo Italiano Trapianto di Midollo Osseo. Allogeneic transplantation improves
• Bruno B, Mordini N, Viviani S, Levis A, Giordano L, Santoro A, Corradini P;
• M, Guidi S, Ciceri F, Bonini A, Ferrari S, Malagola M, Morello E, Milone G,
• 67: Sarina B, Castagna L, Farina L, Patriarca F, Benedetti F, Carella AM, Falda
• 10.1182/b111d . Epub 2010 Apr 14. PMID: 20393132.
• treatment outcome. Blood. 2010 Jun 24;115(25):5137-46. doi:
• in consolidation therapy for high-risk patients: further improvements in
• based on all-trans retinoic acid and anthracycline with addition of cytarabine
• PETHEMA and HOVON Groups. Risk-adapted treatment of acute promyelocytic leukemia
• Díaz-Mediavilla J, Rojas R, Manso F, Ossenkoppele G, González JD, Lowenberg B;
• Lisa E, Brunet S, Rubio V, Ribera JM, Rivas C, Krsnik I, Bergua J, González J,
• 66: Sanz MA, Montesinos P, Rayón C, Holowiecka A, de la Serna J, Milone G, de
• 10.1038/bmt.2010.98. Epub 2010 May 3. PMID: 20436520.
• after failed marrow harvest. Bone Marrow Transplant. 2011 Feb;46(2):314-6. doi:
• for urgent PBSC mobilization and allogeneic transplantation from a normal donor
• 65: Leotta S, Poidomani M, Mauro E, Spadaro A, Marturano E, Milone G. AMD3100
• CD34+ cells from leukapheresis products autografted during the first remission.
• relapse in patients with acute myelocytic leukemia infused with higher doses of
• Cooperative Group for Blood and Marrow Transplantation. Higher incidence of
• Meloni G, Attal M, Bernal T, Rocha V; Acute Leukemia Working Party, European
• 64: Gorin NC, Labopin M, Reiffers J, Milpied N, Blaise D, Witz F, de Witte T,
• Cancer. 2010 Jul 19;10:377. doi: -10-377. PMID: 20642818;
• machinery explain relapse of acute myeloid leukemia after chemotherapy. BMC
• Purrello M. Expression profile and specific network features of the apoptotic
• Majorana A, Statello L, Salito L, Consoli C, Camuglia MG, Di Pietro C, Milone G,
• 63: Ragusa M, Avola G, Angelica R, Barbagallo D, Guglielmino MR, Duro LR,
• Epub 2010 Nov 24. PMID: 21106223.
• Osseo. Hum Pathol. 2011 Feb;42(2):254-68. doi: 10.1016/j.humpath .
• conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo
• examination of graft-versus-host disease in the era of reduced-intensity
• Tendas A, Villari L, Santucci M, Bosi A. The impact of histopathologic
• Patriarca F, Peccatori FA, Ponzoni M, Rafaniello P, Raimondi R, Salomone E,
• Fortunato M, Fratoni S, Guidi S, Messerini L, Milone G, Rapezzi D, Negri G,
• Bonoldi E, Casini M, Cesinaro AM, Ciceri F, Colombetti V, Comin CE, Donelli A,
• 62: Massi D, Fondi C, Nozzoli C, Benemei S, Lapi F, Albarello L, Avellini C,
• Res. 2011 Jul;35(7):899-903. doi: 10.1016/j.leukres Epub 2010 Dec
• filgrastim, in multiple myeloma patients undergoing stem cell mobilization. Leuk
• Lenograstim reduces the incidence of febrile episodes, when compared with
• N, Pastore D, Specchia G, De Paolis MR, Mazza P, Pietrantuono G, Petrini M.
• 61: Orciuolo E, Buda G, Marturano E, Mauro E, Milone G, Cangialosi C, Di Renzo
• Sep;46(9):1278-9. doi: 10.1038/bmt.2010.296. Epub 2011 Jan 10. PMID: 21217784.
• normal donor to an AML patient: a case report. Bone Marrow Transplant. 2011
• cells carrying constitutional Robertsonian translocation from an apparently
• S, Poidomani M, Milone G. Inadvertent transplantation of haematopoietic stem
• 60: Consoli C, Leotta S, Tambè L, Di Marco AL, Avola G, Camuglia MG, Di Mercurio
• or allogeneic transplantation. Bone Marrow Transplant. 2012 Jan;47(1):24-32.
• mobilization in intermediate-risk AML patients treated in first CR by autologous
• Tedeschi P. Prognostic value of CD34+ peak in peripheral blood during
• C, Mercurio S, Romeo MA, Di Marco A, Di Mercurio S, Spadaro A, Palumbo GA,
• 59: Milone G, Poidomani M, Leotta S, Avola G, Camuglia MG, Privitera A, Consoli
• Leukemia. 2011 Oct;25(10):1627-31. doi: 10.1038/leu.2011.131. Epub 2011 Jun 3.
• with newly diagnosed multiple myeloma after lenalidomide induction therapy.
• Musto P, Petrucci MT, Boccadoro M, Palumbo A. Stem cell mobilization in patients
• Patriarca F, Cafro AM, Omedè P, Carella AM, Peccatori J, Catalano L, Caravita T,
• Cascavilla N, Montefusco V, Lupo B, Liberati AM, Crippa C, Rossini F, Passera R,
• 58: Cavallo F, Bringhen S, Milone G, Ben-Yehuda D, Nagler A, Calabrese E,
• for multiple myeloma: a CIBMTR analysis. Blood. 2011 Aug 18;118(7):1979-88. doi:
• Vij R, Kyle RA, Gale RP, Hari PN. Trends in allogeneic stem cell transplantation
• KR, Hamadani M, Lill M, Callander NS, Majhail NS, Wiernik PH, Nath R, Kamble RT,
• Maiolino A, Wirk B, Weiss B, Freytes CO, Vogl DT, Vesole DH, Lazarus HM, Meehan
• 57: Kumar S, Zhang MJ, Li P, Dispenzieri A, Milone GA, Lonial S, Krishnan A,
• Clin Oncol. 2011 Sep 20;29(27):3721. PMID: 21730266.
• 1;29(22):3016-22. doi: 10.1200/JCO Epub 2011 Jul 5. Erratum in: J
• transplantation in myeloma: long-term follow-up. J Clin Oncol. 2011 Aug
• conditioning allogeneic stem-cell transplantation versus autologous
• Morris C, Niederwieser D, Gahrton G. Tandem autologous/reduced-intensity
• F, Musto P, Beksac M, Bosi A, Milone G, Corradini P, Goldschmidt H, de Witte T,
• 56: Björkstrand B, Iacobelli S, Hegenbart U, Gruber A, Greinix H, Volin L, Narni
• myeloma or lymphoma. Biol Blood Marrow Transplant. 2012 Feb;18(2):241-9. doi:
• adequate PBSC collection in predicted poor mobilizer patients with multiple
• E, Olivieri A. Plerixafor added to chemotherapy plus G-CSF is safe and allows
• M, Iacopino P, Milone G, Tedeschi P, Coluzzi S, Nuccorini R, Pascale S, Di Nardo
• 55: Attolico I, Pavone V, Ostuni A, Rossini B, Musso M, Crescimanno A, Martino
• Jun;47(6):831-7. doi: 10.1038/bmt.2011.192. Epub 2011 Sep 26. PMID: 21946381;
• allogeneic transplantation for myeloma. Bone Marrow Transplant. 2012
• and chronic GVHD on relapse and survival after reduced-intensity conditioning
• McCarthy P, Meehan K, Schouten H, Milone GA, Lonial S, Hari PN. Effect of acute
• Kamble R, Freytes CO, Gale RP, Gibson J, Gupta V, Holmberg L, Lazarus H,
• 54: Ringdén O, Shrestha S, da Silva GT, Zhang MJ, Dispenzieri A, Remberger M,
• Jan;40(1):35-47.e2. doi: 10.1016/j.exphem Epub 2011 Oct 20. PMID:
• CD34(+) mobilization and with disease-free survival. Exp Hematol. 2012
• clonogenic precursors in AML patients in complete remission: association with
• Privitera A, Ragusa A, Tibullo D, Di Mercurio S. Chemosensitivity of nonleukemic
• Poidomani M, Coppoletta S, Di Marco AL, Consoli C, Triolo A, Spadaro A,
• 53: Milone G, Avola G, Leotta S, Strano A, Camuglia MG, Pinto V, Mercurio S,
• Hematol. 2012 Jun;91(6):931-9. doi: 011-1395-9. Epub 2012 Jan 14.
• lymphoma relapsed after autologous stem cell transplantation: a GITMO study. Ann
• hematopoietic stem cell transplantation in patients with diffuse large B cell
• R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Allogeneic
• F, Fanin R, Rambaldi A, Falda M, Milone G, Guidi S, Martelli MF, Mazza P, Oneto
• 52: Rigacci L, Puccini B, Dodero A, Iacopino P, Castagna L, Bramanti S, Ciceri
• Transplantation. J Clin Oncol. 2012 Jul 10;30(20):2475-82. doi:
• Chronic Leukemia Working Party of the European Group for Blood and Marrow
• transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the
• in patients with multiple myeloma progressing or relapsing after autologous
• thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone
• Morris C, Gahrton G. Superiority of the triple combination of bortezomib-
• Koenecke C, van Os M, Mohty M, Cakana A, Gorin NC, de Witte T, Harousseau JL,
• Epub 2012 Jul 13. PMID: 22788745.
• outpatient program. Expert Opin Biol Ther. 2012 Nov;12(11):1449-62. doi:
• hematopoietic progenitor cell transplantation for multiple myeloma through an
• Scortechini I, Moscato T, Fedele R, Milone G, Castagna L, Olivieri A. Autologous
• 50: Martino M, Montanari M, Bruno B, Console G, Irrera G, Messina G, Offidani M,
• results of the prospective PREDICT trial. Haematologica. 2013 Feb;98(2):172-8.
• peripheral blood stem cell mobilization in lymphoma and multiple myeloma:
• granulocyte colony-stimulating factor for first-line steady-state autologous
• 49: Russell N, Douglas K, Ho AD, Mohty M, Carlson K, Ossenkoppele GJ, Milone G,
• demand" use of plerixafor. Blood Transfus. 2013 Jan;11(1):94-101. doi:
• later CD34+ mobilisation failure and is a possible criterion for guiding "on
• cyclophosphamide and granulocyte colony-stimulating factor treatment predicts
• Guidi S, Bosi A. Early measurement of CD34+ cells in peripheral blood after
• C, La Fauci A, Amico I, Leotta S, Poidomani M, Irrera G, Iacopino P, Saccardi R,
• 48: Milone G, Tripepi G, Martino M, Ancora F, Bartolozzi B, Spadaro A, Nozzoli
• 23203822.
• 17;121(3):440-6. doi: 10.1182/b111d . Epub 2012 Nov 30. PMID:
• from the European Group for Blood and Marrow Transplantation. Blood. 2013 Jan
• control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study
• Leukemia Working Parties. Stem cell transplantation can provide durable disease
• Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute
• Jardin F, Peters C, Rocha V, Sureda A, Mohty M, Dreger P; European Group for
• Atienza A, Arcese W, Beelen DW, Cornelissen JJ, Kröger N, Milone G, Rossi G,
• 47: Roos-Weil D, Dietrich S, Boumendil A, Polge E, Bron D, Carreras E, Iriondo
• 10.1182/b111d . Epub 2013 Mar 12. PMID: 23482933.
• results of the EBMT-NMAM2000 study. Blood. 2013 Jun 20;121(25):5055-63. doi:
• transplantation vs autologous transplantation in multiple myeloma: long-term
• Disorders Subcommittee. Autologous/reduced-intensity allogeneic stem cell
• Garderet L, Kröger N; EBMT Chronic Malignancies Working Party Plasma Cell
• S, Friberg K, van Biezen A, Goldschmidt H, de Witte T, Morris C, Niederwieser D,
• Volin L, Narni F, Carella AM, Beksac M, Bosi A, Milone G, Corradini P, Schönland
• 46: Gahrton G, Iacobelli S, Björkstrand B, Hegenbart U, Gruber A, Greinix H,
• 2013 Mar 26. PMID: 23538113.
• Marrow Transplant. 2013 Jun;19(6):940-8. doi: 10.1016/j.bbmt.2013.03.012. Epub
• multiple myeloma: study from the Italian Bone Marrow Donor Registry. Biol Blood
• Bruno B. Allogeneic hematopoietic cell transplantation from unrelated donors in
• Rambaldi A, Bacigalupo A, Corradini P, Bosi A, Boccadoro M, Bandini G, Fanin R,
• Milone G, Benedetti F, Ciceri F, Scimè R, Benedetti E, Castagna L, Festuccia M,
• Falda M, Montanari M, Guidi S, Giaccone L, Mordini N, Carella AM, Bavaro P,
• 45: Passera R, Pollichieni S, Brunello L, Patriarca F, Bonifazi F, Montefusco V,
• 10.1002/ajh.23458. Epub 2013 May 30. PMID: 23606215; PMCID: PMC3736162.
• myelodysplastic syndrome. Am J Hematol. 2013 Jul;88(7):581-8. doi:
• of allogeneic hematopoietic stem cell transplantation in patients with
• A, Cazzola M; Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Optimal timing
• R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Rambaldi A, Bosi
• A, Teresa van Lint M, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti
• 44: Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo
• 2013 Apr 22. PMID: 23618688.
• factor. Leuk Res. 2013 Jul;37(7):853-4. doi: 10.1016/j.leukres.2013.03.015. Epub
• hematopoietic transplantation, CD34+ supermobilization is a negative prognostic
• 43: Avola G, Camuglia MG, Milone G. In AML patients treated by allogeneic
• 2013 Jun 19. Erratum in: Transfusion. 2014 Jun;54(6):1688-91. PMID: 23781769.
• and lymphoma. Transfusion. 2014 Feb;54(2):331-9. doi: 10.1111/trf.12265. Epub
• plerixafor: an Italian prospective survey in 215 patients with multiple myeloma
• Martinelli G, Rambaldi A, Bosi A. Factors affecting successful mobilization with
• Imola M, Pasini A, Milone G, Scortechini I, Todisco E, Guggiari E, Cascavilla N,
• 42: Lanza F, Lemoli RM, Olivieri A, Laszlo D, Martino M, Specchia G, Pavone V,
• 23927398.
• Mar;55(3):725-6. doi: Epub 2013 Sep 3. PMID:
• chemotherapy and granulocyte-colony stimulating factor. Leuk Lymphoma. 2014
• mobilization and for on-demand use of plerixafor in patients mobilized by
• 41: Milone G, Tripepi G. Algorithms for early identification of poor
• Aug 6. PMID: 23973731.
• Apher Sci. 2013 Dec;49(3):615-22. doi: 10.1016/j.transci.2013.07.025. Epub 2013
• Società Italiana di Emaferesi e Manipolazione Cellulare (SIdEM) survey. Transfus
• country: results from The Gruppo Italiano Trapianto Midollo Osseo (GITMO) and
• peripheral blood stem cells in multiple myeloma and lymphoma in an European
• P, Olivieri A, Rambaldi A, Bosi A. The costs of mobilisation and collection of
• 40: Pierelli L, Berto P, Accorsi P, Milone G, Lopatriello S, Aiello A, Iacopino
• Aug 27. PMID: 23988403.
• Transplant. 2013 Dec;19(12):1670-6. doi: 10.1016/j.bbmt.2013.08.005. Epub 2013
• from the European group for blood and marrow transplantation. Biol Blood Marrow
• probability estimation for clinical endpoints: a prospective validation study
• Marrow Transplantation Society. Individual quality assessment of autografting by
• Assessment of Haematopoietic Stem Cell Grafting Committee of European Blood and
• S, Farge D, Mohty M, Passweg J, Ruuto T, Madrigal A, Johnsen HE; Quality
• Fiamenghi C, Cuneo A, Knopińska W, Swierkowska-Czeneszew M, Petriz J, Fruehauf
• 39: Lanza F, Campioni DC, Hellmann A, Milone G, Wahlin A, Walewski J, Spedini P,
• 10.1111/bjh.12606. Epub 2013 Oct 21. PMID: 24138497.
• increase in costs. Br J Haematol. 2014 Jan;164(1):113-23. doi:
• improvement in peripheral blood stem cells mobilization and harvest with no
• with chemotherapy and granulocyte colony-stimulating factor: significant
• Di Martina V, Schinocca E, Spina E, Tripepi G. Plerixafor on-demand combined
• 38: Milone G, Martino M, Spadaro A, Leotta S, Di Marco A, Scalzulli P, Cupri A,
• 10.1038/bmt.2013.178. Epub 2013 Nov 18. PMID: 24241579.
• expectations and reality. Bone Marrow Transplant. 2014 Mar;49(3):376-81. doi:
• feasibility of hematopoietic SCT in adults with acute leukemia: planning,
• Transplantation (EBMT). A prospective registration study to determine
• Leukemia Working Party (ALWP) of the European Group for Blood and Marrow
• X, Schäfer-Eckart K, Ruutu T, Milone G, Arcese W, Mohty M, Rocha V; Acute
• 37: Labopin M, Gorin NC, Polge E, Socié G, Gurman G, Gluckman E, Jindra P, Poiré
• 24373120.
• Mycoses. 2014 Jun;57(6):342-50. doi: 10.1111/myc.12161. Epub 2013 Dec 23. PMID:
• fungal diseases in haematological patients: the SEIFEM real-life combo study.
• and efficacy of antifungal combination therapy for proven or probable invasive
• nelle Emopatie Maligne). Multicentre surveillance study on feasibility, safety
• Fanin R, Pagano L; SEIFEM GROUP (Sorveglianza Epidemiologica Infezioni Fungine
• A, Bonini A, Cattaneo C, Melillo L, Caramatti C, Milone G, Scime' R, Picardi M,
• 36: Candoni A, Caira M, Cesaro S, Busca A, Giacchino M, Fanci R, Delia M, Nosari
• 24631738.
• Jun;20(6):872-80. doi: 10.1016/j.bbmt Epub 2014 Mar 14. PMID:
• Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant. 2014
• allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano
• Locasciulli A. Incidence and outcome of invasive fungal diseases after
• Majolino I, Bosi A, Busca A, Arcese W, Bandini G, Bacigalupo A, Rambaldi A,
• Pisapia G, Milone G, Vallisa D, Olivieri A, Bonini A, Castagnola E, Sica S,
• Risitano AM, Russo D, Mordini N, Pastore D, Vacca A, Onida F, Falcioni S,
• Zucchetti E, Bruno B, Irrera G, Patriarca F, Baronciani D, Musso M, Prete A,
• Pecoraro C, Guidi S, Iori AP, Montante B, Chiusolo P, Lanino E, Carella AM,
• 35: Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L,
• 24699116.
• Jul;20(7):1026-32. doi: 10.1016/j.bbmt Epub 2014 Mar 31. PMID:
• an Italian multicenter retrospective study. Biol Blood Marrow Transplant. 2014
• early discharge outpatient model for autografting in multiple myeloma patients:
• (GITMO) – Sezione Trapianto Autologo. Very low rate of readmission after an
• Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare
• L, Milone G, Bruno B, Tripepi G, Lemoli RM, Olivieri A; Gruppo Italiano per il
• Marktel S, Cimminiello M, Messina G, Irrera G, Offidani M, Console G, Castagna
• 34: Martino M, Montanari M, Ferrara F, Ciceri F, Scortechini I, Palmieri S,
• 10.1200/JCO Epub 2014 Apr 14. PMID: 24733807.
• cancer with febrile neutropenia. J Clin Oncol. 2014 May 10;32(14):1463-71. doi:
• piperacillin/tazobactam and tigecycline in high-risk hematologic patients with
• multicenter, controlled, randomized clinical trial evaluating the combination of
• B, Manna A, Zuffa E, Ferrari A, Gentile G, Foà R, Del Favero A. Results of a
• Martinelli G, Offidani M, Chierichini A, Fabbiano F, Quarta G, Primon V, Martino
• Specchia G, Fanci R, Luppi M, Cudillo L, Cantaffa R, Milone G, Bocchia M,
• 33: Bucaneve G, Micozzi A, Picardi M, Ballanti S, Cascavilla N, Salutari P,
• PMID: 25000456.
• Transplant. 2014 Sep;49(9):1193-7. doi: 10.1038/bmt.2014.140. Epub 2014 Jul 7.
• treated with high-dose chemotherapy based on beam or BU-thiothepa. Bone Marrow
• Tripepi G. Palifermin reduces infection rate and hyperfibrinogenemia in patients
• 32: Milone G, Leotta S, Cupri A, Fauci AL, Spina P, Parisi M, Berritta D,
• Oct 13. PMID: 25310302.
• Marrow Transplant. 2015 Feb;50(2):282-8. doi: 10.1038/bmt.2014.231. Epub 2014
• pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. Bone
• Trapianto Midollo Osseo GITMO. Infections by carbapenem-resistant Klebsiella
• Rambaldi A; Gruppo Italiano Trapianto Midollo Osseo (GITMO); Gruppo Italiano
• Sica S, Severino A, Cudillo L, Ciceri F, Scimè R, Lombardini L, Viscoli C,
• 31: Girmenia C, Rossolini GM, Piciocchi A, Bertaina A, Pisapia G, Pastore D,
• PMID: 25318761.
• Hematol. 2015 Apr;94(4):705-6. doi: 014-2235-5. Epub 2014 Oct 16.
• assessment of autologous haematopoietic blood progenitor cell grafting. Ann
• 30: Lanza F, Dallorso S, Milone G, Spedini P, Viganò C, Johnsen H. Quality
• Epub 2015 Jan 26. PMID: 25621805.
• trial. Bone Marrow Transplant. 2015 Apr;50(4):505-10. doi: 10.1038/bmt.2014.310.
• transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective
• Disorders Subcommittee. Impact of CR before and after allogeneic and autologous
• Niederwieser D, Garderet L, Kröger N, Gahrton G; EBMT CMWP, Plasma Cell
• Corradini P, Friberg K, van Biezen A, Goldschmidt H, de Witte T, Morris C,
• A, Greinix H, Volin L, Narni F, Carella AM, Beksac M, Bosi A, Milone G,
• 29: Iacobelli S, de Wreede LC, Schönland S, Björkstrand B, Hegenbart U, Gruber
• 10.1016/j.exphem Epub 2015 Feb 20. PMID: 25704053.
• speed of engraftment. Exp Hematol. 2015 Jun;43(6):430-8.e1. doi:
• allogeneic hematopoietic transplantation affects early marrow reconstitution and
• Romano A, Spina E, Azzaro MP, Berritta D, Parisi M, Tripepi G. Acute GVHD after
• 28: Milone G, Camuglia MG, Avola G, Di Marco A, Leotta S, Cupri A, Spina P,
• 9. PMID: 25751644.
• Marrow Transplant. 2015 Jun;50(6):790-4. doi: 10.1038/bmt.2015.12. Epub 2015 Mar
• transplantation. A retrospective study of the EBMT Lymphoma Working Party. Bone
• allo-SCT in patients with lymphoma relapse after a first allogeneic
• Bacigalupo A, Chalandon Y, Diez-Martin JL, Ifrah N, Chacon MJ, Dreger P. Second
• 27: Horstmann K, Boumendil A, Finke J, Finel H, Kanfer E, Milone G, Russell N,
• doi: 015-0033-1. PMID: 25889496; PMCID: PMC4425876.
• Multiple Myeloma Working Party study. Stem Cell Res Ther. 2015 Apr 17;6(1):64.
• factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto
• agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating
• with multiple myeloma receiving pre-transplant induction therapy with novel
• Boccadoro M. Predicting poor peripheral blood stem cell collection in patients
• Offidani M, Zamagni E, Tacchetti P, Conticello C, Milone G, Palumbo A, Cavo M,
• Pietrantuono G, Villani O, D'Arena G, Cuomo C, Musto C, Morabito F, Petrucci MT,
• 26: Musto P, Simeon V, Grossi A, Gay F, Bringhen S, Larocca A, Guariglia R,
• 26223359; PMCID: PMC4695982.
• Nov;94(11):1875-83. doi: 015-2462-4. Epub 2015 Jul 31. PMID:
• patients treated upfront with novel agents. Ann Hematol. 2015
• ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM
• Pompa A, Corso A, Milone G, Di Raimondo F, Borrello I. Neutrophil to lymphocyte
• 25: Romano A, Parrinello NL, Consoli ML, Marchionni L, Forte S, Conticello C,
• Sep 28. PMID: 26429297.
• Oncol. 2015 Nov;16(15):1525-1536. doi: . Epub 2015
• myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. Lancet
• for allogeneic haemopoietic stem-cell transplantation in patients with acute
• plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen
• GF, Scimè R, Mordini N, Oldani E, Marfisi RM, Bacigalupo A, Bosi A. Busulfan
• Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Alessandrino EP, Torelli
• D, Guidi S, Patriarca F, Risitano AM, Saporiti G, Pini M, Terruzzi E, Arcese W,
• Cavattoni I, Santarone S, Raimondi R, Montanari M, Milone G, Chiusolo P, Pastore
• 24: Rambaldi A, Grassi A, Masciulli A, Boschini C, Micò MC, Busca A, Bruno B,
• 7;374(1):43-53. doi: 10.1056/NEJMoa1506002. PMID: 26735993.
• Prevention of Chronic Graft-versus-Host Disease. N Engl J Med. 2016 Jan
• E, Narni F, Völp A, Ayuk F, Ruutu T, Bonifazi F. Antilymphocyte Globulin for
• Petrini M, Milone G, Benedetti F, Heinzelmann M, Pastore D, Jurado M, Terruzzi
• AM, Cimminiello M, Guidi S, Finke J, Mordini N, Ferra C, Sierra J, Russo D,
• Selleri C, Risitano A, Messina G, Bethge W, Pérez de Oteiza J, Duarte R, Carella
• 23: Kröger N, Solano C, Wolschke C, Bandini G, Patriarca F, Pini M, Nagler A,
• 26762681; PMCID: PMC4801761.
• Apr;22(4):744-751. doi: 10.1016/j.bbmt Epub 2016 Jan 4. PMID:
• American Caucasian and Japanese Populations. Biol Blood Marrow Transplant. 2016
• Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North
• Atsuta Y, Saber W. Graft-versus-Host Disease after HLA-Matched Sibling Bone
• A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T,
• Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi
• 22: Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y,
• 27021516.
• 2016 May;56(5):1096-1100. doi: 10.1111/trf.13523. Epub 2016 Mar 28. PMID:
• antibodies before T-cell-replete haploidentical transplantation. Transfusion.
• with plasma exchange in a patient with human leukocyte antigen donor-specific
• Timofeeva I, Capizzuto R, Carlo-Stella C, Santoro A, Castagna L. Desensitization
• 21: Bramanti S, Nocco A, Mauro E, Milone G, Morabito L, Sarina B, Crocchiolo R,
• doi: 10.1038/bmt.2016.79. Epub 2016 Apr 4. PMID: 27042841.
• management in multiple myeloma. Bone Marrow Transplant. 2016 Aug;51(8):1032-40.
• consensus conference for the outpatient autologous stem cell transplantation
• M, Scortechini I, Montanari M, Milone G, Postacchini L, Olivieri A. Italian
• 20: Martino M, Lemoli RM, Girmenia C, Castagna L, Bruno B, Cavallo F, Offidani
• 10.1097/CAD . PMID: 27101258; PMCID: PMC4936475.
• mitochondrial-bound hexokinase. Anticancer Drugs. 2016 Aug;27(7):609-19. doi:
• peptide of Lactobacillus casei peptidoglycan and its interaction with
• 19: Fichera GA, Fichera M, Milone G. Antitumoural activity of a cytotoxic
• 10.1016/j.bbmt Epub 2017 Apr 5. PMID: 28390983.
• Regimen. Biol Blood Marrow Transplant. 2017 Jul;23(7):1102-1109. doi:
• Prospective Trial including Rituximab in the Reduced-Intensity Conditioning
• for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II
• Narni F, Farina L, Rambaldi A, Corradini P. Allogeneic Stem Cell Transplantation
• Terruzzi E, Mussetti A, Pini M, Bosi A, Dominietto A, Cascavilla N, Onida F,
• 18: Dodero A, Patriarca F, Milone G, Sarina B, Miceli R, Iori A, Barretta F,
• 10.1016/j.bbmt Epub 2017 May 10. PMID: 28499937.
• Prophylaxis. Biol Blood Marrow Transplant. 2017 Sep;23(9):1549-1554. doi:
• Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease
• Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple
• Maura F, de Philippis C, Bruno B, Furst S, Blaise D, Corradini P, Montefusco V.
• 17: Castagna L, Mussetti A, Devillier R, Dominietto A, Marcatti M, Milone G,
• Epub 2017 Jun 2. PMID: 28573902.
• multiple myeloma. Leuk Lymphoma. 2018 Jan;59(1):42-48. doi:
• colony stimulating factor for peripheral blood stem cell mobilization in
• effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-
• Camuglia MG, Di Marco A, Scalzulli P, Morelli M, Olivieri A, Tripepi G. Cost-
• 16: Milone G, Martino M, Leotta S, Spadaro A, Zammit V, Cupri A, Avola G,
• PMID: 28971905; PMCID: PMC5709112.
• 2017 Dec;102(12):2125-2133. doi: 10.3324/haematol Epub 2017 Sep 29.
• graft-versus-host disease grade I: a randomized trial. Haematologica.
• Italiano Trapianto di Midollo Osseo (GITMO). Steroid treatment of acute
• Gualandi F, Selleri C, Sormani MP, Signori A, Risitano A, Bonifazi F; Gruppo
• S, Chiusolo P, Sica S, Mammoliti S, Sorasio R, Massi D, Van Lint MT, Raiola AM,
• 15: Bacigalupo A, Milone G, Cupri A, Severino A, Fagioli F, Berger M, Santarone
• 13;65(11):1884-1896. doi: 10.1093/cid/cix690. PMID: 29020286.
• Italian Prospective Multicenter Survey. Clin Infect Dis. 2017 Nov
• After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An
• Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia
• Midollo Osseo (GITMO) and Associazione Microbiologi Clinici Italiani (AMCLI).
• C, Viscoli C, Rossolini GM, Bonifazi F, Rambaldi A; Gruppo Italiano Trapianto di
• Pastore D, Alessandrino EP, Annaloro C, Ciceri F, Santarone S, Nassi L, Farina
• G, Scimè R, Musso M, Cudillo L, Sica S, Castagna L, Corradini P, Marchesi F,
• Cattaneo C, Raiola AM, Guidi S, Iori AP, Candoni A, Irrera G, Milone G, Marcacci
• 14: Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A,
• 10.1038/bmt.2017.223. Epub 2017 Oct 30. PMID: 29084200.
• Midollo Osseo (GITMO). Bone Marrow Transplant. 2018 Jan;53(1):58-63. doi:
• report on the management of chronic GvHD in the Gruppo Italiano Trapianto
• Tecchio C, Vassallo E, Chiarucci M, Bruno B, Bonifazi F, Olivieri A. 'Real-life'
• Raimondi R, Rovelli A, Santarone S, Severino A, Skert C, Stanghellini MTL,
• Iori AP, Marotta S, Micò MC, Milone G, Onida F, Pastore D, Patriarca F, Pini M,
• Cimminiello M, Colombo AA, Facchini L, Falcioni S, Faraci M, Fedele R, Guidi S,
• Arpinati M, Baronciani D, Bozzoli V, Bramanti S, Calore E, Cavattoni IM,
• 13: Giaccone L, Mancini G, Mordini N, Gargiulo G, De Cecco V, Angelini S,
• 017-0026-z. Epub 2017 Dec 21. PMID: 29269809.
• GITMO/IBMDR study. Bone Marrow Transplant. 2018 Mar;53(3):291-299. doi:
• transplantation for acute leukemia in different macro-regions of Italy. A
• Rambaldi A, Bonifazi F. Access to alternative donor hematopoietic search and
• 12: Milone G, Sacchi N, Gallina A, Leotta S, Picardi A, Guidi S, Tripepi G,
• 017-0051-y. Epub 2018 Jan 12. PMID: 29330395.
• mobilizer (pPM) score. Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi:
• hematopoietic stem cell mobilization before it starts: the predicted poor
• Milone G, Saraceni F, Di Nardo E, Perseghin P, Olivieri A. Predicting failure of
• P, Capria S, Merli F, Codeluppi K, Mele G, Lanza F, Specchia G, Pastore D,
• Martino M, Moscato T, Pini M, Zallio F, Ciceri F, Marktel S, Mengarelli A, Musto
• Corradini P, Farina L, Gaidano G, Nassi L, Sica S, Piccirillo N, Pioltelli PE,
• 11: Olivieri J, Attolico I, Nuccorini R, Pascale SP, Chiarucci M, Poiani M,
• 10.1111/bjh.15454. Epub 2018 Jul 9. PMID: 29984825.
• Party and FIL-GITMO. Br J Haematol. 2018 Sep;182(6):807-815. doi:
• in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working
• Montoto S, Conconi A. High-dose therapy and autologous stem cell transplantation
• D, Guilhot F, Kroschinsky F, Wahlin B, Scheid C, Ifrah N, Berthou C, Dreger P,
• M, Bourhis JH, Caillot D, Haenel A, Held G, Thieblemont C, Jindra P, Pohlreich
• Liliana D, Musso M, Didier B, Bachy E, Wattad M, Nicolas-Virelizier E, Gramatzki
• 10: Avivi I, Arcaini L, Ferretti VV, Boumendil A, Finel H, Milone G, Zaja F,
• 2018;63(4):220-224. doi: . Epub 2018 Oct 29. PMID: 30372691.
• Hematopoietic Stem Cell Transplantation: A Case Report. Chemotherapy.
• Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic
• Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient
• Calafiore V, Mauro E, Spadaro A, Vigneri P, Di Raimondo F, Milone G. Long-Term
• 9: Pirosa MC, Leotta S, Cupri A, Stella S, Martino EA, Scalise L, Sapienza G,
• 10.1016/j.bbmt Epub 2018 Dec 20. PMID: 30579966.
• Biol Blood Marrow Transplant. 2019 May;25(5):932-940. doi:
• in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
• Trapianti di Midollo Osseo. (GITMO).. Busulfan- or Thiotepa-Based Conditioning
• Bruno B, Mammoliti S, Bruno B, Fanin R, Bonifazi F, Rambaldi A; Gruppo Italiano
• Bosi A, Russo D, Narni F, Messina G, Alessandrino EP, Carella AM, Milone G,
• 8: Patriarca F, Masciulli A, Bacigalupo A, Bregante S, Pavoni C, Finazzi MC,
• Jan;39(1):431-435. doi: 10.21873/anticanres.13130. PMID: 30591491.
• e14a2 BCR-ABL Transcripts: A Case Report. Anticancer Res. 2019
• After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to
• Puma A, Romano C, Stagno F, Sapienza G, Milone G, Manzella L. B-ALL Relapses
• 7: Stella S, Massimino M, Tirrò E, Vitale SR, Scalise L, Leotta S, Pennisi MS,
• Mar;6(3):e121. PMID: 30709437.
• doi: X. Erratum in: Lancet Haematol. 2019
• analysis of a phase 3 randomised study. Lancet Haematol. 2019 Feb;6(2):e89-e99.
• leukaemia in remission: final results of quality of life and long-term outcome
• transplantation from HLA-identical siblings in patients with acute myeloid
• after myeloablative allogeneic haemopoietic peripheral blood stem-cell
• E, Narni F, Völp A, Ayuk F, Ruutu T, Kröger N. Acute GVHD prophylaxis plus ATLG
• Benedetti E, Milone G, Benedetti F, Heinzelmann M, Pastore D, Jurado M, Terruzzi
• Cimminiello M, Guidi S, Finke J, Sorasio R, Ferra C, Sierra J, Russo D,
• Selleri C, Risitano AM, Messina G, Bethge W, Herrera P, Sureda A, Carella AM,
• 6: Bonifazi F, Solano C, Wolschke C, Sessa M, Patriarca F, Zallio F, Nagler A,
• 10.1016/j.bbmt Epub 2019 Mar 30. PMID: 30935966.
• Biol Blood Marrow Transplant. 2019 Jul;25(7):1387-1394. doi:
• Cell Transplantation: A Study by the Gruppo Italiano Trapianto Di Midollo Osseo.
• of Donor and Recipient Gender on Telomere Maintenance after Umbilical Cord Blood
• Santarone S, Bosi A, Rambaldi A, Bacigalupo AP, Arcese W, Tarella C. Influence
• 5: Derenzini E, Risso A, Ruella M, Spatola T, Milone G, Pioltelli P, Iori AP,
• 10.4084/MJHID.2019.048. PMID: 31528314; PMCID: PMC6736170.
• Patients. Mediterr J Hematol Infect Dis. 2019 Sep 1;11(1):e2019048. doi:
• Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted
• Velardi A, Foà R, Ciceri F, Russo D, Peccatori J. CMV Management with Specific
• N, Turra A, Cattina F, Gandolfi L, Rambaldi B, Lorentino F, Serio F, Milone G,
• W, Bruzzese A, Leotta S, Carotti A, Pierini A, Bernardi S, Morello E, Polverelli
• 4: Malagola M, Greco R, Santarone S, Natale A, Iori AP, Quatrocchi L, Barbieri
• . Epub 2019 Sep 18. PMID: 31533095.
• Multiple Lines of Chemotherapy. Chemotherapy. 2019;64(2):110-114. doi:
• Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to
• Villari L, Conticello C, Milone G. Pomalidomide-Responsive Extramedullary
• MA, Martino EA, Curto Pelle A, Leotta V, Milone G, Cupri A, Vaddinelli D,
• 3: Leotta S, Pirosa MC, Markovic U, Scalise L, Bulla A, Sapienza G, Di Giorgio
• 10.3389/fimmu PMID: 32117211; PMCID: PMC7020780.
• Transplantation. Front Immunol. 2020 Feb 7;10:3158. doi:
• Based on sIL2-Rα and TIM-3 Levels Assayed Early After Hematopoietic
• Marchese AE, Crocchiolo R, Milone G. Preliminary Results of a Combined Score
• Pelle A, Markovic U, Milone GA, Cupri A, Bianco O, Frontini V, Spadaro A,
• 2: Leotta S, Sapienza G, Camuglia MG, Avola G, Marco AD, Moschetti G, Curto
• print. PMID: 32388535.
• Marrow Transplant. 2020 May 10. doi: 020-0936-z. Epub ahead of
• in acute myeloid leukemia patients autografted in first complete remission. Bone
• Esteve J, Gorin NC, Mohty M, Nagler A. Risk stratification using FLT3 and NPM1
• Forcade E, Huynh A, Saccardi R, Milone G, Zuckerman T, Reményi P, Versluis J,
• 1: Shouval R, Labopin M, Bomze D, Baerlocher GM, Capria S, Blaise D, Hänel M,

• Piastrinopenia
• Anemia
• linfoma
• Leucemia
• Immunodeficienza
• Gammapatie monoclonali
• patologie genetiche
• Emocromatosi
• Leucemia Mieloide Cronica
• Leucemie croniche